logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Pierre Bories

department of hematology
H指数:26
被引数:3,249

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

大B细胞淋巴瘤CAR T细胞疗法后的应答动力学：DESCAR-T登记研究中的LYSA研究

Bone Marrow Transplantation
IF5.2
2026-08-210
PRE
Guillaume Manson; Roberta Di Blasi; Roch Houot; Franck Morschhauser; Guillaume Cartron; Thomas Gastinne; Didier Blaise; François-Xavier Gros; Pierre Bories; Fabien Le Bras; Marie-Thérèse Rubio; Mohammad Mohty; Jacques-Olivier Bay; Stéphanie Guidez; Cristina Castilla Llorente; Fabrice Jardin; Amandine Durand; Blandine Guffroy; Michaël Loschi; Laurianne Drieu La Rochelle; Julie Abraham; Adrien Chauchet; Laura Herbreteau; Sylvain Choquet; Magalie Joris; Sylvain Carras; Gandhi-Laurent Damaj; Justine Decroocq; Tanguy-Schmidt Aline; Olivier Hermine; Emmanuelle Nicolas-Virelizier; Elodie Gat; Steven Le Gouill; Emmanuel Bachy; Remy Dulery
Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm

对10 326例疑似骨髓增殖性肿瘤患者进行JAK2、CALR和MPL的靶向下一代测序

American Journal of Hematology
IF9.9
2026-08-100
OAAI
Lucie Rigolot; Mathias Chea; Laetitia Largeaud; Naïs Prade; Stéphanie Dufrechou; Pauline Condom; Thomas Lhossein; Pierre-Yves Juvin; Julie Riol; Elise Frébet; Hugo Migné; Isabelle Legoff; Carole Boivert; Barnabé Daniau; Philippe Gueudet; Pierre Bories; Françoise Huguet; Suzanne Tavitian; Eric Delabesse; Véronique De Mas
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group

二线CAR T细胞治疗后进展的大B细胞淋巴瘤的结局和挽救策略：LYSA小组的DESCAR-T研究

HemaSphere
IF14.6
2026-05-060
OAAI
Sesques, Pierre; Manson, Guillaume; Cartron, Guillaume; Gros, Francois-Xavier; Morschhauser, Franck; Castilla-Llorente, Cristina; Brisou, Gabriel; Bories, Pierre; Thieblemont, Catherine; La Rochelle, Laurianne Drieu; Tessoulin, Benoit; Andre, Axel; Rossi, Cedric; Paillassa, Jerome; Guidez, Stephanie; Capes, Antoine; Herbreteau, Laura; Choquet, Sylvain; Bay, Jacques-Olivier; Chauchet, Adrien; Lebras, Laure; Claves, Fabien; Abraham, Julie; Malfuson, Jean-Valere; Rubio, Marie-Therese; Decroocq, Justine; Fornecker, Luc-Matthieu; Damaj, Gandhi; Fouillet, Ludovic; Joris, Magalie; Loschi, Michael; Hermine, Olivier; Hafirassou, Hadia; Van Zele, Emelie; Dupont, Vivien; Le Gouill, Steven; Houot, Roch; Camus, Vincent
Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registry

CAR T细胞疗法后侵袭性B细胞淋巴瘤的晚期复发：一项来自DESCAR-T登记研究的LYSA研究

Blood Advances
IF7.1
2025-10-240
OAAI
Federico Erbella; Emmanuel Bachy; Guillaume Cartron; Elodie Gat; Guillaume Manson; Franck Morschhauser; Francois-Xavier Gros; Louise Roulin; Benoit Tessoulin; Pierre Bories; Olivier Tournilhac; Laure Ricard; Stéphanie Guidez; Sylvain Choquet; Rene-Olivier Casasnovas; Gabriel Brisou; Arnaud Campidelli; Cristina Castilla-Llorente; Fabrice Jardin; Emmanuel Gyan; Blandine Guffroy; Julie Abraham; Justine Decroocq; Adrien Chauchet; Magalie Joris; Fabien Claves; Sylvain Carras; Gaëlle Guillerm; Michaël Loschi; Olivier Hermine; Aline Taguy-Schimidt; Steven Le Gouill; Roch Houot; Roberta Di Blasi
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

从ide-cel早期复发后使用靶向BCMA的双特异性抗体治疗效果不佳：一项法国真实世界研究

Blood Advances
IF7.1
2025-09-200
OAAI
Sarah Cayla; Lionel Karlin; Jérôme Lambert; Anne Lazareth; Alexis Talbot; Mohamad Mohty; Florent Malard; Marie-Odile Petillon; Salomon Manier; Ibrahim Yakoub-Agha; Denis Caillot; Ingrid Lafon; Xavier Leleu; Niels Moya; Bruno Royer; Jean-Marc Schiano De Colella; Gabriel Brisou; Cyrille Touzeau; Aurore Perrot; Pierre Bories; Laure Vincent; Hanane Guedon; Olivier Decaux; Benoît Ferment; Roch Houot; Steven Le Gouill; Noémie Bigot; Thierry Facon; Jill Corre; Hervé Avet-Loiseau; Philippe Moreau; Bertrand Arnulf
Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma

真实世界证据支持将Venetoclax作为t(11;14)骨髓瘤患者的附加治疗选择。

clinical lymphoma myeloma leukemia
IF0
2025-04-140
PRE
Jules Higué; Gaetan Basile; Titouan Cazaubiel; Julie Gay; Guillaume Béziat; Martin Gauthier; Miguel Carreiro; Noémie Gadaud; François Lifermann; Reza Tabrizi; Benjamin Hébraud; Miguel Granell; Léopoldine Lapierre; Pierre-Luc Mouchel; Pierre Bories; Jill Corre; Cyrille Hulin; Aurore Perrot
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial

口服混合粪菌疗法在强化化疗后重建肠道微生物组：CIMON 1b 期试验

Blood Advances
IF7.1
2025-04-100
OA
Florent Malard; Sylvain Thepot; Thomas Cluzeau; Martin Carré; Delphine Lebon; Pierre Bories; Ollivier Legrand; Marianne Schwarz; Michael Loschi; Mathieu Meunier; Magalie Joris; Cyrielle Gasc; Juliette Jouve; Benoît Levast; Emilie Plantamura; Emmanuel Prestat; Antoine Sabourin; Béatrice Gaugler; Joel Dore; Christian Récher; Mohamad Mohty
Real-World Multicenter Data of Venetoclax Use in Multiple Myeloma with t(11-14). Time to Consider It Again

真实世界中t(11-14)型多发性骨髓瘤使用Venetoclax的多中心数据。是时候再次考虑它了。

BLOOD
IF23.1
2024-11-050
PRE
Higue, Jules; Basile, Gaetan; Cazaubiel, Titouan; Banos, Anne; Beziat, Guillaume; Gauthier, Martin; Carreiro, Miguel; Gadaud, Noemie; Hebraud, Benjamin; Granell, Miguel; Bories, Pierre; Recher, Christian; Corre, Jill; Hulin, Cyrille; Perrot, Aurore; Lapierre, Leopoldine; Mouchel, Pierre Luc
French Regional Experience of Pre-CAR-T Cells Lymphodepleting Chemotherapy Outcourced in the Patient's Referring Center

法国区域性预CAR-T细胞淋巴清除化疗 outsourced 在患者转诊中心

BLOOD
IF23.1
2024-11-050
PRE
Dumont, Anne; Beziat, Guillaume; Gadaud, Noemie; Ghenim, Leila; Gauthier, Martin; Thomazeau, Josephine; Vergez, Francois; Spinau, Coline; Vicente, Celine; De Barros, Sandra; Despas, Fabien; Rey, Solene; Pajiep-Chapda, Marie Christelle; Guenounou, Sarah; Cazaux, Marine; Borel, Cecile; Perrot, Aurore; Ysebaert, Loic; Recher, Christian; Huynh, Anne; Bories, Pierre
Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma
JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2024-08-061
OAAI
Sesques, Pierre; Kirkwood, Amy A.; Kwon, Mi; Rejeski, Kai; Jain, Michael D.; Di Blasi, Roberta; Brisou, Gabriel; Gros, Francois-Xavier; le Bras, Fabien; Bories, Pierre; Choquet, Sylvain; Rubio, Marie-Therese; Iacoboni, Gloria; O'Reilly, Maeve; Casasnovas, Rene-Olivier; Bay, Jacques-Olivier; Mohty, Mohamad; Joris, Magalie; Abraham, Julie; Llorente, Cristina Castilla; Loschi, Mickael; Carras, Sylvain; Chauchet, Adrien; La Rochelle, Laurianne Drieu; Hermine, Olivier; Guidez, Stephanie; Cony-Makhoul, Pascale; Fogarty, Patrick; Le Gouill, Steven; Morschhauser, Franck; Gastinne, Thomas; Cartron, Guillaume; Subklewe, Marion; Locke, Frederick L.; Sanderson, Robin; Barba, Pere; Houot, Roch; Bachy, Emmanuel
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
HAEMATOLOGICA
IF7.9
2024-06-202
OAAI
Herbaux, Charles; Bret, Caroline; Bachy, Emmanuel; Bories, Pierre; Di Blasi, Roberta; Cuffel, Alexis; Gastinne, Thomas; Lamy, Thierry; Roussel, Mikael; Bouabdallah, Krimo; Beauvais, David; Cartron, Guillaume; Bay, Jacques-Olivier; Blaise, Didier; Rubio, Marie-Therese; Mohty, Mohamad; Le Bras, Fabien; Casasnovas, Olivier; Guy, Julien; Guidez, Stephanie; Llorente, Cristina Castilla; Hermine, Olivier; La Rochelle, Laurianne Drieu; Carras, Sylvain; Guffroy, Blandine; Caillat-Zucman, Sophie; Houot, Roch; Le Gouill, Steven
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
BLOOD ADVANCES
IF7.1
2023-10-3023
OAAI
Lemoine, Jean; Bachy, Emmanuel; Cartron, Guillaume; Beauvais, David; Gastinne, Thomas; Di Blasi, Roberta; Rubio, Marie-Therese; Guidez, Stephanie; Mohty, Mohamad; Casasnovas, Rene-Olivier; Joris, Magalie; Castilla-Llorente, Cristina; Haioun, Corinne; Hermine, Olivier; Loschi, Michael; Carras, Sylvain; Bories, Pierre; Fradon, Tom; Herbaux, Charles; Sesques, Pierre; Le Gouil, Steven; Morschhauser, Franck; Thieblemont, Catherine; Houot, Roch
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trial

克唑替尼治疗儿童、青少年和成年患者ALK阳性系统性间变性大细胞淋巴瘤的疗效和安全性: 法国acsé-crizotinib试验结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-09-0110
OAAI
Brugieres, Laurence; Cozic, Nathalie; Houot, Roch; Rigaud, Charlotte; Sibon, David; Arfi-Rouche, Julia; Bories, Pierre; Cottereau, Anne S.; Delmer, Alain; Ducassou, Stephane; Garnier, Nathalie; Lamant, Laurence; Leruste, Amaury; Millot, Frederic; Moalla, S.; Morschhauser, Franck; Nolla, Marie; Pagnier, Anne; Reguerre, Yves; Renaud, Loic; Schmitt, Anne; Simonin, Mathieu; Verschuur, Arnaud; Labouret, Nathalie Hoog; Oukhatar, Celine Mahier Ait; Vassal, Gilles
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
LEUKEMIA
IF13.4
2023-06-147
OAAI
Ocio, Enrique M.; Perrot, Aurore; Bories, Pierre; San-Miguel, Jesus F.; Blau, Igor W.; Karlin, Lionel; Martinez-Lopez, Joaquin; Wang, Song-Yau; Bringhen, Sara; Marcatti, Magda; Mateos, Maria-Victoria; Rodriguez-Otero, Paula; Oliva, Stefania; Nogai, Axel; Le Roux, Nadia; Dong, Liyan; Mace, Sandrine; Gassiot, Matthieu; Fitzmaurice, Thomas; Oprea, Corina; Moreau, Philippe
Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia
CLINICAL CANCER RESEARCH
IF10.2
2022-11-0112
OA
Canali, Alban; Vergnolle, Ines; Bertoli, Sarah; Largeaud, Laetitia; Nicolau, Marie-Laure; Rieu, Jean-Baptiste; Tavitian, Suzanne; Huguet, Francoise; Picard, Muriel; Bories, Pierre; Vial, Jean Philippe; Lechevalier, Nicolas; Bene, Marie Christine; Luquet, Isabelle; Mansat-De Mas, Veronique; Delabesse, Eric; Recher, Christian; Vergez, Francois
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
NATURE MEDICINE
IF50
2022-09-22191
OAAI
Bachy, Emmanuel; Le Gouill, Steven; Di Blasi, Roberta; Sesques, Pierre; Manson, Guillaume; Cartron, Guillaume; Beauvais, David; Roulin, Louise; Gros, Francois Xavier; Rubio, Marie Therese; Bories, Pierre; Bay, Jacques Olivier; Llorente, Cristina Castilla; Choquet, Sylvain; Casasnovas, Rene-Olivier; Mohty, Mohamad; Guidez, Stephanie; Joris, Magalie; Loschi, Michael; Carras, Sylvain; Abraham, Julie; Chauchet, Adrien; La Rochelle, Laurianne Drieu; Deau-Fischer, Benedicte; Hermine, Olivier; Gastinne, Thomas; Tudesq, Jean Jacques; Gat, Elodie; Broussais, Florence; Thieblemont, Catherine; Houot, Roch; Morschhauser, Franck

研究方向

暂未获取到该数据
S
Steven Le Gouill
H 指数:69论文数:705被引数:1.8万
C
Christian Récher
H 指数:81论文数:1,076被引数:2.5万
O
Olivier Casasnovas
H 指数:86论文数:635被引数:2.4万
R
Roch Houot
H 指数:60论文数:497被引数:1.3万
R
Roberta Di Blasi
H 指数:29论文数:130被引数:4,307
G
Guillaume Cartron
H 指数:68论文数:632被引数:1.8万
M
Mohamad Mohty
H 指数:126论文数:2,145被引数:6.3万
E
Emmanuel Bachy
H 指数:48论文数:534被引数:1.0万
A
Aurore Perrot
H 指数:43论文数:452被引数:1.1万
M
Michaël Loschi
H 指数:23论文数:167被引数:2,952